PATENT CLAIM ANALYSIS

Application Number: 15755792
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "013300"]

Abstract:
The present invention relates to novel cyclic peptidomimetics, pharmaceutical compositions containing them and their use in the treatment of diseases associated with angiogenesis especially tumors and chronic inflammation in psoriasis, diabetes, degenerative diseases of the eye (ARMD), nephropathy and neuropathy.

Claim (Index 9):
Use a compound as defined in  claim 1  for the manufacture of a medicament for the treatment of diseases associated with angiogenesis.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.23684
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14913380', '13886864', '13311817', '14379484', '14024961']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650601826260202
- 35 USC 102 Novelty (BERT): 0.5446921058340763
- Combined Prediction Score: 0.7430233749468258
- Mean Citation Score: 302.682876
- Max Citation Score: 377.87958
- Similarity Product: 243.66182371896028

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test